This inventor holds 3 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignee: Imaginab, Inc.. Active years: 2019-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019-2025
Title: Giti Agahi: Innovator in Antigen Binding Constructs
Introduction
Giti Agahi is a prominent inventor based in Los Angeles, CA. He has made significant contributions to the field of biotechnology, particularly in the development of antigen binding constructs. With a total of 3 patents to his name, Agahi's work is paving the way for advancements in medical treatments.
Latest Patents
Giti Agahi's latest patents focus on antigen binding constructs to CD8. These constructs include antibodies and antibody fragments, such as scFv, minibodies, and cys-diabodies, that specifically bind to CD8. The patents describe various methods of use for these constructs, highlighting their potential applications in therapeutic settings.
Career Highlights
Agahi is currently associated with Imaginab, Inc., where he continues to innovate and develop new technologies. His work has garnered attention in the scientific community, contributing to the advancement of targeted therapies.
Collaborations
Some of Giti Agahi's notable coworkers include David T. Ho and Tove Olafsen, who have collaborated with him on various projects. Their combined expertise enhances the research and development efforts at Imaginab, Inc.
Conclusion
Giti Agahi's contributions to the field of biotechnology through his patents and collaborations are noteworthy. His work on antigen binding constructs is set to make a significant impact in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile